Latest Breaking News On - Analyst recommendations for rhythm pharmaceuticals - Page 2 : comparemela.com

Rhythm Pharmaceuticals (RYTM) Buy Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) in a research report released on Friday morning, Benzinga reports. They currently have a $50.00 target price on the stock. A number of other equities analysts also recently commented on RYTM. The Goldman Sachs Group upped their target […]

Davidp meekerHunterc smithWells fargo companySilverarc capital managementGoldman sachs groupBarclays plcVictory capital management incNews ratings for rhythm pharmaceuticals dailyRhythm pharmaceuticals incRhythm pharmaceuticals stock performanceAnalyst recommendations for rhythm pharmaceuticalsNeedham companyRhythm pharmaceuticalsInstitutional investors weigh in on rhythm pharmaceuticalsCharles schwab investment management incFree report

Rhythm Pharmaceuticals (NASDAQ:RYTM) PT Lowered to $52 00 at Wells Fargo & Company

Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) had its target price lowered by Wells Fargo & Company from $53.00 to $52.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other equities analysts have also recently weighed in on the stock. Needham & Company […]

Joseph shulmanHunterc smithRhythm pharmaceuticals company profileRhythm pharmaceuticalsRhythm pharmaceuticals stock performanceAnalyst recommendations for rhythm pharmaceuticalsNeedham companyPerceptive advisorsBlackrock incGoldman sachs groupGeode capital managementWells fargo companySecurities exchange commissionNews ratings for rhythm pharmaceuticals dailyInstitutional investors weigh in on rhythm pharmaceuticalsRhythm pharmaceuticals inc

Rhythm Pharmaceuticals (RYTM) Buy Rating Reaffirmed at Needham & Company LLC

Rhythm Pharmaceuticals (RYTM) Buy Rating Reaffirmed at Needham & Company LLC
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Joseph shulmanDavidp meekerAnalyst recommendations for rhythm pharmaceuticalsSilverarc capital managementRhythm pharmaceuticalsVictory capital management incNews ratings for rhythm pharmaceuticals dailyWells fargo companySecurities exchange commissionNeedham companyBarclays plcGoldman sachs groupMorgan stanleyCharles schwab investment management incRhythm pharmaceuticals incInstitutional trading of rhythm pharmaceuticals

Rhythm Pharmaceuticals, Inc (NASDAQ:RYTM) Given Average Rating of Buy by Brokerages

Rhythm Pharmaceuticals, Inc (NASDAQ:RYTM) Given Average Rating of Buy by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesHunterc smithJoseph shulmanRhythm pharmaceuticals company profileNeedham companyRhythm pharmaceuticalsLife insurance coAnalyst recommendations for rhythm pharmaceuticalsGoldman sachs groupRhythm pharmaceuticals stock performanceChina universal asset management coMorgan stanleyWells fargo companyNews ratings for rhythm pharmaceuticals dailyChicago partners investment groupInstitutional investors weigh in on rhythm pharmaceuticals

Brokerages Set Rhythm Pharmaceuticals, Inc (NASDAQ:RYTM) Price Target at $46 86

Brokerages Set Rhythm Pharmaceuticals, Inc (NASDAQ:RYTM) Price Target at $46 86
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Hunterc smithJoseph shulmanNisa investment advisorsRhythm pharmaceuticals incChina universal asset management coMorgan stanleyInstitutional trading of rhythm pharmaceuticalsRhythm pharmaceuticals trading downSecurities exchange commissionNews ratings for rhythm pharmaceuticals dailyRhythm pharmaceuticalsWells fargo companyGoldman sachs groupAnalyst recommendations for rhythm pharmaceuticalsRhythm pharmaceuticals company profileNeedham company